# Recombinant BNP on Heart and Renal Function in Acute Heart Failure

> **NCT01625403** · PHASE2 · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Acute Heart Failure
- Acute Renal Failure

## Interventions

- **DRUG:** rhBNP
- **DRUG:** standard of care

## Key facts

- **NCT ID:** NCT01625403
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01625403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01625403, "Recombinant BNP on Heart and Renal Function in Acute Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01625403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*